A noncoding RNA regulates human protease-activated receptor-1 gene during embryogenesis.

Activation of the human protease-activated receptor-1 (PAR-1) by thrombin leads to myriad functions essential for maintaining vascular integrity. Upregulation of PAR-1 expression is considered important in atherosclerosis, angiogenesis and tumor metastasis. In vitro analysis of the human PAR-1 promoter function revealed a positive regulatory element between -4.2 and -3.2 kb of the transcription start site. This element was examined in transgenic mice containing either 4.1 or 2.9 kb of the 5' flanking sequence driving a LacZ reporter gene. Only the 4.1 kb PAR-1 transgene was expressed in vivo and only during embryonic development. The transgene expression was observed only in developing arteries and not in veins. Further examination of this putative regulatory sequence identified a novel noncoding RNA (ncR-uPAR:noncoding RNA upstream of the PAR-1) gene at -3.4 kb. The ncR-uPAR upregulated PAR-1-core promoter-driven luciferase activity and mRNA expression in vitro in a Pol II-dependent manner. This noncoding RNA appears to act in trans, albeit locally at the adjacent PAR-1 promoter. These data suggest that an untranslated RNA plays a role in PAR-1 gene expression during embryonic growth.

[1]  R. Ohlsson,et al.  Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis. , 1997, Cancer research.

[2]  H. Anderson,et al.  Combination of Inhibition of Thrombin and Blockade of Thromboxane A2 Synthetase and Receptors Enhances Thrombolysis and Delays Reocclusion in Canine Coronary Arteries , 1992, Circulation.

[3]  K. Miyazono,et al.  Identification of a Novel Bone Morphogenetic Protein-responsive Gene That May Function as a Noncoding RNA* , 1998, The Journal of Biological Chemistry.

[4]  B. Hogan,et al.  Manipulating the mouse embryo: A laboratory manual , 1986 .

[5]  S. Coughlin,et al.  Thrombin signalling and protease-activated receptors , 2000, Nature.

[6]  Helen M. Blau,et al.  Genetic complementation reveals a novel regulatory role for 3′ untranslated regions in growth and differentiation , 1993, Cell.

[7]  M. Robson,et al.  Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. , 1992, The Journal of clinical investigation.

[8]  Helen M. Blau,et al.  Tumor suppression by RNA from the 3′ untranslated region of α-tropomyosin , 1993, Cell.

[9]  M. Runge,et al.  Cloning and Identification of Regulatory Sequences of the Human Thrombin Receptor Gene* , 1996, The Journal of Biological Chemistry.

[10]  Robert V Farese,et al.  A dual thrombin receptor system for platelet activation , 1998, Nature.

[11]  R. Lefkowitz,et al.  Mitogenic signaling via G protein-coupled receptors. , 1996, Endocrine reviews.

[12]  S. Coughlin,et al.  Protease-activated receptor 3 is a second thrombin receptor in humans , 1997, Nature.

[13]  P. Lasko,et al.  Requirement for a Noncoding RNA in Drosophila Polar Granules for Germ Cell Establishment , 1996, Science.

[14]  Thiennu H. Vu,et al.  Thrombin receptor expression in normal and atherosclerotic human arteries. , 1992, The Journal of clinical investigation.

[15]  B. Tycko,et al.  Role of the H19 gene in Syrian hamster embryo cell tumorigenicity , 1997, Molecular carcinogenesis.

[16]  J. Pouysségur,et al.  cDNA cloning and expression of a hamster α‐thrombin receptor coupled to Ca2+ mobilization , 1991 .

[17]  J. Rossant,et al.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.

[18]  Lieve Moons,et al.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.

[19]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[20]  W. S. Hayward,et al.  bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA , 1997, Molecular and cellular biology.

[21]  H. Kleinman,et al.  Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. , 1997, The American journal of physiology.

[22]  S. Coughlin,et al.  Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. , 1994, The American journal of pathology.

[23]  N. Hernandez,et al.  A 7 bp mutation converts a human RNA polymerase II snRNA promoter into an RNA polymerase III promoter , 1989, Cell.

[24]  J. P. Hobson,et al.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.

[25]  S. Schwartz,et al.  Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells. , 1992, Circulation research.

[26]  Reuven Reich,et al.  Thrombin receptor overexpression in malignant and physiological invasion processes , 1998, Nature Medicine.

[27]  J. Steitz,et al.  A mammalian gene with introns instead of exons generating stable RNA products , 1996, Nature.

[28]  P. A. Peterson,et al.  Biological Consequences of Thrombin Receptor Deficiency in Mice , 1996, Thrombosis and Haemostasis.

[29]  C. Francis,et al.  Markers of Hemostatic Activation in Affected Coronary Arteries during Angioplasty , 1994, Thrombosis and Haemostasis.

[30]  V. Ambros,et al.  The Cold Shock Domain Protein LIN-28 Controls Developmental Timing in C. elegans and Is Regulated by the lin-4 RNA , 1997, Cell.

[31]  S. Coughlin,et al.  Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. , 1993, The Journal of clinical investigation.

[32]  J. Mattick,et al.  The evolution of controlled multitasked gene networks: the role of introns and other noncoding RNAs in the development of complex organisms. , 2001, Molecular biology and evolution.

[33]  Stefan Offermanns,et al.  Vascular System Defects and Impaired Cell Chemokinesis as a Result of Gα13 Deficiency , 1997, Science.

[34]  J. Mattick.  Non‐coding RNAs: the architects of eukaryotic complexity , 2001, EMBO reports.

[35]  Benjamin Tycko,et al.  Tumour-suppressor activity of H19 RNA , 1993, Nature.

[36]  P. Grabham,et al.  Cellular consequences of thrombin-receptor activation. , 1996, The Biochemical journal.

[37]  Thomas N. Sato,et al.  Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation , 1995, Nature.

[38]  J. Merlie,et al.  A novel synapse-associated noncoding RNA , 1994, Molecular and cellular biology.

[39]  S. Eddy.  Non–coding RNA genes and the modern RNA world , 2001, Nature Reviews Genetics.

[40]  Effects of thrombin receptor activating peptide on phosphoinositide hydrolysis and protein kinase C activation in cultured rat aortic smooth muscle cells: evidence for "tethered-ligand" activation of smooth muscle cell thrombin receptors. , 1993, Biochemical pharmacology.

[41]  M. Kuroda,et al.  Guilt by association: non-coding RNAs, chromosome-specific proteins and dosage compensation in Drosophila. , 1999, Trends in genetics : TIG.

[42]  C. Betsholtz,et al.  Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.

[43]  J. Gutkind.  The Pathways Connecting G Protein-coupled Receptors to the Nucleus through Divergent Mitogen-activated Protein Kinase Cascades* , 1998, The Journal of Biological Chemistry.

[44]  W. Filipowicz,et al.  U6 snRNA genes of Arabidopsis are transcribed by RNA polymerase III but contain the same two upstream promoter elements as RNA polymerase II-transcribed U-snRNA genes. , 1990, Nucleic acids research.

[45]  W. Stumph,et al.  Role of TATA box sequence and orientation in determining RNA polymerase II/III transcription specificity. , 1996, Nucleic acids research.

[46]  S. Coughlin,et al.  A Role for Thrombin Receptor Signaling in Endothelial Cells During Embryonic Development , 2001, Science.

[47]  Robert V Farese,et al.  Role of the thrombin receptor in development and evidence for a second receptor , 1996, Nature.

[48]  A. Mantovani,et al.  Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. , 1994, The American journal of pathology.

[49]  R. Kelley,et al.  Noncoding RNA Genes in Dosage Compensation and Imprinting , 2000, Cell.

[50]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[51]  K. Griendling,et al.  Thrombin signal transduction mechanisms in rat vascular smooth muscle cells. Calcium and protein kinase C-dependent and -independent pathways. , 1990, The Journal of biological chemistry.

[52]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[53]  R. Busse,et al.  Thrombin receptor expression is increased by angiotensin II in cultured and native vascular smooth muscle cells. , 1998, Cardiovascular research.

[54]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[55]  W. Filipowicz,et al.  Alteration of the RNA polymerase specificity of U3 snRNA genes during evolution and in vitro , 1991, Cell.

[56]  R. Busse,et al.  Serotonin stimulates the expression of thrombin receptors in cultured vascular smooth muscle cells. Role of protein kinase C and protein tyrosine kinases. , 1996, Circulation.

[57]  J. Folkman,et al.  Blood Vessel Formation: What Is Its Molecular Basis? , 1996, Cell.

[58]  C. Orvain,et al.  Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[59]  Carolyn J. Brown,et al.  Evolutionary conservation of possible functional domains of the human and murine XIST genes. , 1993, Human molecular genetics.

[60]  David A. Willoughby,et al.  An Alu Element from the K18 Gene Confers Position-independent Expression in Transgenic Mice* , 2000, The Journal of Biological Chemistry.

[61]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[62]  Samin K. Sharma,et al.  Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty. , 1994, Journal of the American College of Cardiology.

[63]  B. Sollner-Webb,et al.  Novel intron-encoded small nucleolar RNAs , 1993, Cell.

[64]  Huntington F. Willard,et al.  Remodelling chromatin with RNA , 1997, Nature.

[65]  A. Lumsden,et al.  Characterization of thrombin receptor expression during vascular lesion formation. , 1994, Circulation research.

[66]  D. Askew,et al.  New insights into the function of noncoding RNA and its potential role in disease pathogenesis. , 1999, Histology and histopathology.

[67]  W. Stumph,et al.  RNA polymerase II/III transcription specificity determined by TATA box orientation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[68]  S. Rastan,et al.  Requirement for Xist in X chromosome inactivation , 1996, Nature.